On April 8, 2019, ALJ Cheney issued an order denying the
addition of an email to the exhibit list at the eve of the
evidentiary hearing. Certain Strontium-Rubidium Radioisotope
Infusion Systems, and Components Thereof Including Generators,
Inv. 337-TA-1110, Order No. 33. We have previously reported on this
investigation
(here).
In our previous post, we reported that the ALJ denied
Respondents' Motion to Supplement their Notice of Prior Art to
include several non-patent publications because the Respondents did
not explain why these references were not obtained earlier or how
these references pertained to the asserted patents.
At issue in this instance is an email produced on January 22,
2019 by Respondents Jubilant DraxImage, Inc., Jubilant Pharma
Limited, and Jubilant Life Sciences Limited (collectively
"Jubilant") – five months after the close of fact
discovery. On March 29, 2019, right before the evidentiary hearing,
Jubilant moved for leave to supplement its